AnalystsAnanda GhoshAnanda Ghosh's Stock Forecasts
AnalystsAnanda Ghosh
Sectors:
Industries:
Analyst Ranking
Top 18%
#936 out of 5224 analysts
Average Return
+27.15%
Win Rate
50%11 out of 22
Risk vs Reward
Poor
Good
Ananda Ghosh's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Structure Therapeutics IncGPCR | +202.84% | $16.20 | $49.06 | 2025-08-06 - 2026-03-23 | Buy |
Maze Therapeutics IncMAZE | +177.78% | $17.64 | $49.00 | 2025-07-22 - 2026-03-23 | Buy |
Annexon IncANNX | +120.08% | $2.44 | $5.37 | 2025-08-14 - 2026-03-23 | Buy |
Maze Therapeutics IncMAZE | +110.35% | $23.30 | $49.00 | 2025-09-11 - 2026-03-23 | Buy |
Maze Therapeutics IncMAZE | +108.69% | $23.48 | $49.00 | 2025-09-17 - 2026-03-23 | Buy |
Ananda Ghosh Analyst Color
Get additional color on Ananda Ghosh's coverage of popular stocks
Ananda Ghosh's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Structure Therapeutics IncGPCR | 4 | Buy | $100.00 | +103.83% | Maintains | 8 days ago |
Dyne Therapeutics IncDYN | 3 | Buy | $50.00 | +179.80% | Maintains | 21 days ago |
Acadia Pharmaceuticals IncACAD | 2 | Buy | $37.00 | +76.27% | Reiterates | 2 months ago |
Stoke Therapeutics IncSTOK | 1 | Buy | $50.00 | +49.70% | Maintains | 3 months ago |
Maze Therapeutics IncMAZE | 4 | Buy | $60.00 | +22.45% | Maintains | 4 months ago |
Pepgen IncPEPG | 3 | Buy | $20.00 | +318.41% | Maintains | 4 months ago |
Avidity Biosciences IncRNAM | 2 | Hold | $72.00 | +388.14% | Downgrades | 5 months ago |
Inventiva SaIVA | 2 | Buy | $24.00 | +294.74% | Maintains | 5 months ago |
Skye Bioscience IncSKYE | 1 | Buy | $20.00 | +3,015.26% | Initiates Coverage On | 6 months ago |
Annexon IncANNX | 1 | Buy | $14.00 | +160.71% | Reiterates | 7 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.